Table 3.
Metabolite | Expression Pattern | Tissue Type | Method | Ref |
---|---|---|---|---|
Arachidonic acid, 12-HETE (hydroxyeicosatetraenoic acid) | Higher/higher | chronic plaque psoriasis skin | GC-MS | 57 |
α-ketoglutaric acid, asparagine, glutamine, glucuronic acid | Higher/lower/lower/higher | Psoriatic patient serum | GC-TOF-MS | 58 |
Threonine, ornithine, and methionine | Lower/lower/lower | Plasma from mild or severe psoriasis | LC-MS | 59 |
Glucose, myo-inositol, taurine, choline | Higher/higher/lower/lower | Lesional psoriatic skin | MR spectroscopy | 60 |
Homocysteine, ADMA, citrulline | Higher/higher/lower | chronic plaque psoriasis blood | HPLC–MS | 61 |
Choline, glutamic acid, phenylalanine, lactic acid, urocanic acid, citrulline | Higher/higher/higher/lower/lower/lower | Lesional psoriatic skin | nano-DESI MS | 62 |
Crotonic acid, azelaic acid, ethanolamine, and cholesterol | Lower/lower/ lower/lower |
Psoriatic patients’ serum | GC-MS | 63 |
citrate, alanine, methylsuccinate, trigonelline, carnitine, and hippurate | lower | Psoriatic patients’ urine | NMR | 64 |
tetranor-12(S)-HETE,12(S)-HETE | Higher/lower | Psoriatic patients’ urine | HPLC–MS-MS | 65 |
Abbreviations: GC-MS, gas chromatography mass spectrometry; GC-TOF-MS, gas chromatography time-of-flight mass spectrometry; LC-MS, liquid chromatography mass spectrometry; MR spectroscopy, magnetic resonance spectroscopy; HPLC-MS, high performance liquid chromatography mass spectrometry; nano-DESI MS, nanospray desorption electrospray ionization mass spectrometry; NMR, nuclear magnetic resonance.